Filings under RPRX by Repros Therapeutics Inc. (CIK 0000897075) from May 2, 2006 to Jan 31, 2018 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Hite Christopher | EVP & Chairman, Partnering | Gift(G) | 17K | — | $0 |
| Aug 18, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 100K | $59.97 | $6.0M |
| Aug 13, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 2K | $59.14 | $105K |
| Aug 13, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 9K | $58.59 | $541K |
| Aug 7, 2026 | Coyne Terrance P. | EVP & CFO | Gift(G) | 19K | — | $0 |
| Aug 7, 2026 | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Gift(G) | 30K | — | $0 |
| Aug 7, 2026 | Urist Marshall | EVP, Research & Investments | Gift(G) | 3K | — | $0 |
| Aug 5, 2026 | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant(A) | 65K | — | $0 |
| Aug 5, 2026 | Urist Marshall | EVP, Research & Investments | Grant(A) | 8K | — | $0 |
| Aug 5, 2026 | Coyne Terrance P. | EVP & CFO | Grant(A) | 11K | — | $0 |
| Aug 5, 2026 | Hite Christopher | EVP & Chairman, Partnering | Grant(A) | 11K | — | $0 |
| Jul 1, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 9K | $55.88 | $508K |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 97K | $56.50 | $5.5M |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 3K | $57.10 | $146K |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 29K | $56.44 | $1.7M |
| Jun 30, 2026 | Bassler Bonnie L | Director | Grant(A) | 689 | $54.40 | $37K |
| Jun 30, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 600 | $57.09 | $34K |
| Jun 24, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 9K | $55.18 | $502K |
| Jun 23, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 32K | $54.11 | $1.8M |
| Jun 23, 2026 | Hite Christopher | EVP & Chairman, Partnering | Sell(S) | 118K | $54.47 | $6.4M |
| Jun 5, 2026 | Hodgson David C | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Coric Vlad | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Engelbert Catherine M. | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Ho Carole | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Bassler Bonnie L | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Weatherman Elizabeth H | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Norden Gregory | Director | Grant(A) | 5K | — | $0 |
| Jun 5, 2026 | Love Ted W | Director | Grant(A) | 5K | — | $0 |
| May 26, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 64K | $53.98 | $3.5M |
| May 20, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 14K | $52.75 | $722K |
| May 14, 2026 | Norden Gregory | Director | Sell(S) | 3K | $53.00 | $161K |
| May 14, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 14K | $53.06 | $726K |
| May 6, 2026 | Coyne Terrance P. | EVP & CFO | Grant(A) | 24K | — | $0 |
| May 6, 2026 | Hite Christopher | EVP & Vice Chairman | Grant(A) | 24K | — | $0 |
| May 6, 2026 | Urist Marshall | EVP, Research & Investments | Grant(A) | 18K | — | $0 |
| May 6, 2026 | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant(A) | 144K | — | $0 |
| Apr 28, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 33K | $49.78 | $1.6M |
| Apr 28, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 2K | $49.78 | $93K |
| Apr 1, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 33K | $48.33 | $1.6M |
| Apr 1, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 2K | $48.33 | $91K |
| Mar 31, 2026 | Bassler Bonnie L | Director | Grant(A) | 815 | $45.98 | $37K |
| Mar 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 2K | $45.53 | $85K |
| Mar 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 33K | $45.53 | $1.5M |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 583 | $47.01 | $27K |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 22K | $46.67 | $1.0M |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 10K | $47.01 | $490K |
| Mar 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 1K | $46.67 | $60K |
| Feb 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 2K | $45.32 | $85K |
| Feb 23, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 33K | $45.32 | $1.5M |
| Feb 11, 2026 | Hite Christopher | EVP & Vice Chairman | Grant(A) | 27K | — | $0 |
| Feb 11, 2026 | Coyne Terrance P. | EVP & CFO | Grant(A) | 27K | — | $0 |
| Feb 11, 2026 | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant(A) | 158K | — | $0 |
| Feb 11, 2026 | Urist Marshall | EVP, Research & Investments | Grant(A) | 20K | — | $0 |
| Feb 4, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 19K | $43.29 | $826K |
| Feb 4, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 1K | $43.29 | $47K |
| Feb 3, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 109K | $42.84 | $4.7M |
| Feb 3, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 6K | $42.84 | $265K |
| Feb 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 6K | $42.08 | $246K |
| Feb 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 103K | $42.08 | $4.3M |
| Jan 30, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $41.09 | $822K |
| Jan 23, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $40.26 | $805K |
| Jan 20, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 4K | $39.35 | $148K |
| Jan 20, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 66K | $39.35 | $2.6M |
| Jan 16, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $39.52 | $790K |
| Jan 9, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $40.78 | $816K |
| Jan 2, 2026 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $38.48 | $770K |
| Jan 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 66K | $38.42 | $2.5M |
| Jan 2, 2026 | Coyne Terrance P. | EVP & CFO | Sell(S) | 4K | $38.42 | $144K |
| Dec 31, 2025 | Bassler Bonnie L | Director | Grant(A) | 967 | $38.74 | $37K |
| Dec 26, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $39.32 | $786K |
| Dec 19, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $38.38 | $768K |
| Dec 18, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 31K | $38.50 | $1.2M |
| Dec 17, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 79K | $38.57 | $3.1M |
| Dec 16, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 20K | $38.32 | $766K |
| Dec 15, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 66K | $38.36 | $2.5M |
| Dec 15, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 4K | $38.36 | $144K |
| Dec 5, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 18K | $39.15 | $714K |
| Dec 5, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 23K | $39.15 | $914K |
| Dec 3, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 110K | $39.77 | $4.4M |
| Dec 1, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 66K | $39.87 | $2.6M |
| Dec 1, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 4K | $39.87 | $150K |
| Dec 1, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 18K | $39.90 | $728K |
| Dec 1, 2025 | Urist Marshall | EVP, Research & Investments | Sell(S) | 23K | $39.93 | $932K |
| Nov 24, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 11K | $37.96 | $406K |
| Nov 24, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 3K | $38.67 | $121K |
| Nov 24, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 624 | $37.96 | $24K |
| Nov 24, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 55K | $38.67 | $2.1M |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 2K | $39.01 | $96K |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 3K | $38.29 | $106K |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 26K | $38.28 | $977K |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 47K | $38.28 | $1.8M |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 5K | $39.01 | $181K |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 48K | $38.28 | $1.8M |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 5K | $39.01 | $179K |
| Nov 19, 2025 | Lloyd George W. | EVP, Investments & CLO | Sell(S) | 230 | $39.03 | $9K |
| Nov 17, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 4K | $39.30 | $147K |
| Nov 17, 2025 | Coyne Terrance P. | EVP & CFO | Sell(S) | 66K | $39.30 | $2.6M |
| Nov 7, 2025 | Urist Marshall | EVP, Research & Investments | Conversion(C) | 16K | — | $0 |
| Nov 7, 2025 | Urist Marshall | EVP, Research & Investments | Conversion(C) | 160K | — | $0 |
| Nov 5, 2025 | Urist Marshall | EVP, Research & Investments | Grant(A) | 5K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Royalty Pharma plc, SEC CIK 0001802768. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under RPRX and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-10. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for RPRX